European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I

European Urology
Susanne KregeH von der Maase

Abstract

The first consensus report presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the auspices of the Department of Urology of the Amsterdam Medical Center, Amsterdam, The Netherlands. Medical oncologists, urological surgeons, radiation oncologists as well as pathologists from several European countries reviewed and discussed the data that had emerged since the 2002 conference, and incorporated the new data into updated and revised guidelines. As for the first meeting, the methodology of evidence-based medicine (EBM) was applied. The results of the discussion were compiled by the writing committee. All participants have agreed to this final update. The first part of the consensus paper describes the clinical presentation of the primary tumor, its treatment, the importance and treatment of testicular intraepithelial neoplasia (TIN), histological classification, staging and prognostic factors, and treatment of stage I seminoma and non-seminoma. Whereas the vast majority of the recommendations made in 2004 remain valid 3 yr later, refinements in the treatment of early- and advance...Continue Reading

Associated Clinical Trials

References

Sep 1, 1991·Clinical Oncology : a Journal of the Royal College of Radiologists·G Madej, A Pawinski
Jul 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A GiwercmanA Marks
Jan 1, 1996·Medical and Pediatric Oncology·S KlieschE Nieschlag
Jun 15, 1993·International Journal of Radiation Oncology, Biology, Physics·M A Dosmann, G K Zagars
Mar 1, 1995·The Journal of Urology·C C CapeloutoK R Loughlin
Jan 1, 1994·World Journal of Urology·A GiwercmanN E Skakkebaek
Jan 1, 1995·The Journal of Urology·L Weissbach
Jul 17, 1993·BMJ : British Medical Journal·L DoddsG Sherman
Sep 1, 1993·International Journal of Radiation Oncology, Biology, Physics·P R WardeA J Munro
Jan 1, 1993·Journal of Cancer Research and Clinical Oncology·K P DieckmannV Loy
Apr 1, 1993·International Journal of Andrology·K P Dieckmann, V Loy
Mar 1, 1996·The Journal of Urology·I LeibovitchJ P Donohue
May 1, 1996·International Journal of Radiation Oncology, Biology, Physics·I C KiricutaW Bohndorf
May 29, 1996·International Journal of Cancer. Journal International Du Cancer·T WestergaardM Melbye
Mar 1, 1996·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·S D FossåS Serbouti
Nov 5, 1997·Journal of the National Cancer Institute·L B TravisJ D Boice
Feb 25, 1998·The Journal of Urology·P C SoganiG Bosl
Apr 3, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·K P Dieckmann, V Loy
Sep 5, 1998·The Urologic Clinics of North America·D B Lashley, B A Lowe
Sep 5, 1998·The Urologic Clinics of North America·C N Sternberg
Apr 21, 1999·Clinical Radiology·P M WhiteA R Wright
Sep 11, 1999·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·W A WeberM Schwaiger
Sep 24, 1999·JAMA : the Journal of the American Medical Association·J G LijmerP M Bossuyt
Dec 1, 1999·Current Opinion in Urology·S D FossåC F Haaland
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·M BambergM Flink
Sep 29, 2000·BMJ : British Medical Journal·R JacobsenH Moller
Nov 7, 2001·The Journal of Urology·A HeidenreichUNKNOWN German Testicular Cancer Study Group
Nov 22, 2001·Journal of the National Cancer Institute·J T HartmannC Bokemeyer
Feb 28, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ScholzU E Studer

❮ Previous
Next ❯

Citations

Feb 25, 2011·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Rainer SouchonRichard Cathomas
Jun 21, 2008·Der Urologe. Ausg. A·L Weissbach, C Schaefer
Dec 11, 2008·Der Urologe. Ausg. A·S Krege
Mar 3, 2009·Der Urologe. Ausg. A·A HeidenreichR Souchon
Mar 10, 2010·Der Urologe. Ausg. A·M SeitzC Stief
Aug 19, 2010·Der Urologe. Ausg. A·D PfisterA Heidenreich
Apr 20, 2011·Der Urologe. Ausg. A·M HartmannUNKNOWN Interdisziplinäre Arbeitsgruppe Hodentumore
Apr 25, 2012·Der Urologe. Ausg. A·L Lusuardi, G Janetschek
Oct 16, 2013·Der Urologe. Ausg. A·A Lorch, P Albers
Aug 28, 2013·Der Urologe. Ausg. A·F ZengerlingM Schrader
Apr 18, 2009·World Journal of Urology·Jan OldenburgSophie D Fosså
Jun 12, 2009·World Journal of Urology·Nathan Lawrentschuk, Neil Fleshner
Sep 17, 2008·Journal of Cancer Survivorship : Research and Practice·H S HaugnesR M Bremnes
Apr 2, 2009·Current Oncology Reports·Ann Tan, Timothy Gilligan
Jan 5, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Josep Ma PiulatsJosé R Germà-Lluch
Aug 9, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Jorge AparicioDolores Isla
Dec 25, 2013·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·G Lopez-FontanaC Maurin
May 21, 2013·Asian Journal of Andrology·Zhao-Jie LvZhi-Ming Cai
Jul 10, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H-J SchmollUNKNOWN ESMO Guidelines Working Group
Jul 10, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H-J SchmollUNKNOWN ESMO Guidelines Working Group
Jan 14, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K-P DieckmannUNKNOWN German Testicular Cancer Study Group
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H-J SchmollUNKNOWN ESMO Guidelines Working Group
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H-J SchmollUNKNOWN ESMO Guidelines Working Group
May 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K HashimotoY Fujiwara
May 26, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Honecker, C Bokemeyer
Oct 12, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C KollmannsbergerC Nichols
Oct 30, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J L Passos-CoelhoA C Miranda
Oct 30, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MassardK Fizazi
Jan 8, 2011·Journal of the National Cancer Institute·Peter Chung, Padraig Warde
Feb 25, 2011·Onkologie·Richard CathomasUNKNOWN interdisziplinäre Arbeitsgruppe Hodentumore
Sep 23, 2011·Onkologie·Jörg T Hartmann, Anja Lorch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Critical Reviews in Oncology/hematology
R J GrollMichael A S Jewett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Alexandra W van den Belt-DuseboutFlora E van Leeuwen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Padraig WardeH von der Maase
© 2021 Meta ULC. All rights reserved